Literature DB >> 33886011

Syringe Coverage Among People Who Inject Drugs in West Virginia, USA.

Sean T Allen1, Rebecca Hamilton White2, Allison O'Rourke3, Kristin E Schneider4, Brian W Weir2, Gregory M Lucas5, Michael E Kilkenny6, Susan G Sherman2.   

Abstract

Ensuring people who inject drugs (PWID) have ≥ 100% sterile syringe coverage (i.e., persons have access to a sterile syringe for all injections) is optimal for HIV prevention. Existing syringe coverage literature is informative, yet little work has examined syringe coverage among PWID in rural communities. Using data from a 2018 PWID population estimation study conducted in a rural county in West Virginia, we used logistic regression to identify correlates of adequate sterile syringe coverage (at least 100%). A minority (37%) of PWID reported having adequate syringe coverage. Factors inversely associated with adequate syringe coverage included having recently (past 6 months): engaged in transactional sex work, shared syringes, and injected fentanyl. Having exclusively acquired syringes from a syringe services program was associated with increased odds of adequate syringe coverage. Rural PWID may benefit from tailored interventions designed to increase sterile syringe access.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  HIV; People who inject drugs; Rural health; Syringe services program

Mesh:

Substances:

Year:  2021        PMID: 33886011     DOI: 10.1007/s10461-021-03247-3

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  46 in total

1.  Sterile syringe access conditions and variations in HIV risk among drug injectors in three cities.

Authors:  Ricky N Bluthenthal; Mohammed Rehan Malik; Lauretta E Grau; Merrill Singer; Patricia Marshall; Robert Heimer
Journal:  Addiction       Date:  2004-09       Impact factor: 6.526

2.  Emerging epidemic of hepatitis C virus infections among young nonurban persons who inject drugs in the United States, 2006-2012.

Authors:  Anil G Suryaprasad; Jianglan Z White; Fujie Xu; Beth-Ann Eichler; Janet Hamilton; Ami Patel; Shadia Bel Hamdounia; Daniel R Church; Kerri Barton; Chardé Fisher; Kathryn Macomber; Marisa Stanley; Sheila M Guilfoyle; Kristin Sweet; Stephen Liu; Kashif Iqbal; Rania Tohme; Umid Sharapov; Benjamin A Kupronis; John W Ward; Scott D Holmberg
Journal:  Clin Infect Dis       Date:  2014-08-11       Impact factor: 9.079

3.  County-Level Vulnerability Assessment for Rapid Dissemination of HIV or HCV Infections Among Persons Who Inject Drugs, United States.

Authors:  Michelle M Van Handel; Charles E Rose; Elaine J Hallisey; Jessica L Kolling; Jon E Zibbell; Brian Lewis; Michele K Bohm; Christopher M Jones; Barry E Flanagan; Azfar-E-Alam Siddiqi; Kashif Iqbal; Andrew L Dent; Jonathan H Mermin; Eugene McCray; John W Ward; John T Brooks
Journal:  J Acquir Immune Defic Syndr       Date:  2016-11-01       Impact factor: 3.731

4.  Incidence and transmission patterns of acute hepatitis C in the United States, 1982-2006.

Authors:  Ian T Williams; Beth P Bell; Wendi Kuhnert; Miriam J Alter
Journal:  Arch Intern Med       Date:  2011-02-14

5.  HIV Infection Linked to Injection Use of Oxymorphone in Indiana, 2014-2015.

Authors:  Philip J Peters; Pamela Pontones; Karen W Hoover; Monita R Patel; Romeo R Galang; Jessica Shields; Sara J Blosser; Michael W Spiller; Brittany Combs; William M Switzer; Caitlin Conrad; Jessica Gentry; Yury Khudyakov; Dorothy Waterhouse; S Michele Owen; Erika Chapman; Jeremy C Roseberry; Veronica McCants; Paul J Weidle; Dita Broz; Taraz Samandari; Jonathan Mermin; Jennifer Walthall; John T Brooks; Joan M Duwve
Journal:  N Engl J Med       Date:  2016-07-21       Impact factor: 91.245

6.  Community Outbreak of HIV Infection Linked to Injection Drug Use of Oxymorphone--Indiana, 2015.

Authors:  Caitlin Conrad; Heather M Bradley; Dita Broz; Swamy Buddha; Erika L Chapman; Romeo R Galang; Daniel Hillman; John Hon; Karen W Hoover; Monita R Patel; Andrea Perez; Philip J Peters; Pam Pontones; Jeremy C Roseberry; Michelle Sandoval; Jessica Shields; Jennifer Walthall; Dorothy Waterhouse; Paul J Weidle; Hsiu Wu; Joan M Duwve
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-05-01       Impact factor: 17.586

7.  Estimating the number of persons who inject drugs in the united states by meta-analysis to calculate national rates of HIV and hepatitis C virus infections.

Authors:  Amy Lansky; Teresa Finlayson; Christopher Johnson; Deborah Holtzman; Cyprian Wejnert; Andrew Mitsch; Deborah Gust; Robert Chen; Yuko Mizuno; Nicole Crepaz
Journal:  PLoS One       Date:  2014-05-19       Impact factor: 3.240

8.  Illicit Drug Use, Illicit Drug Use Disorders, and Drug Overdose Deaths in Metropolitan and Nonmetropolitan Areas - United States.

Authors:  Karin A Mack; Christopher M Jones; Michael F Ballesteros
Journal:  MMWR Surveill Summ       Date:  2017-10-20

9.  Opioid Overdose Outbreak - West Virginia, August 2016.

Authors:  Joel Massey; Michael Kilkenny; Samantha Batdorf; Sarah K Sanders; Debra Ellison; John Halpin; R Matthew Gladden; Danae Bixler; Loretta Haddy; Rahul Gupta
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2017-09-22       Impact factor: 17.586

10.  Increases in hepatitis C virus infection related to injection drug use among persons aged ≤30 years - Kentucky, Tennessee, Virginia, and West Virginia, 2006-2012.

Authors:  Jon E Zibbell; Kashif Iqbal; Rajiv C Patel; Anil Suryaprasad; Kathy J Sanders; Loretta Moore-Moravian; Jamie Serrecchia; Steven Blankenship; John W Ward; Deborah Holtzman
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-05-08       Impact factor: 17.586

View more
  1 in total

1.  Latent Classes of Polysubstance Use and Associations with HIV Risk and Structural Vulnerabilities among Cisgender Women Who Engage in Street-Based Transactional Sex in Baltimore City.

Authors:  Sam Wilson Beckham; Jennifer L Glick; Kristin E Schneider; Sean T Allen; Lillian Shipp; Rebecca Hamilton White; Ju Nyeong Park; Susan G Sherman
Journal:  Int J Environ Res Public Health       Date:  2022-03-22       Impact factor: 3.390

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.